The DOI matches its Crossref record; 269 of the 269 references it cites were found in a registry or an index.
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Abstract
Initially, gene therapy was viewed as an approach for treating hereditary diseases, but its potential role in the treatment of acquired diseases such as cancer is now widely recognized. The understanding of the molecular mechanisms involved in cancer and the development of nucleic acid delivery systems are two concepts that have led to this development. Systemic gene delivery systems are needed for therapeutic application to cells inaccessible by percutaneous injection and for multi-located tumor sites, i.e. metastases. Non-viral vectors based on the use of cationic lipids or polymers appear to have promising potential, given the problems of safety encountered with viral vectors. Using these non-viral vectors, the current challenge is to obtain a similarly effective transfection to viral ones. Based on the advantages and disadvantages of existing vectors and on the hurdles encountered with these carriers, the aim of this review is to describe the "perfect vector" for systemic gene therapy against cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–269 of 269
Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands
Pedersen, N. M., Hansen, S. H., Heydenreich, A. V., Kristensen, H. G., & Poulsen, H. S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.09.003 · Cited by 131
Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides
Fattal, E., Vauthier, C., Aynié, I., Nakada, Y., Lambert, G., Malvy, C., & Couvreur, P. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00246-0 · Cited by 129
Okuda, T., Kawakami, S., Akimoto, N., Niidome, T., Yamashita, F., & Hashida, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.012 · Cited by 128
Kim, I., Lee, S., Park, Y., Lee, Y., Shin, S.-C., Lee, K. C., & Oh, I.-J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.04.017 · Cited by 128
Green, J. J., Chiu, E., Leshchiner, E. S., Shi, J., Langer, R., & Anderson, D. G. (2007) · Nano Letters · doi:10.1021/nl062395b · Cited by 128
Gene delivery with low molecular weight linear polyethylenimines
Breunig, M., Lungwitz, U., Liebl, R., Fontanari, C., Klar, J., Kurtz, A., Blunk, T., & Göpferich, A. M. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.775 · Cited by 125
Shir, A., Ogris, M., Wagner, E., & Levitzki, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030006 · Cited by 124
Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers
Dennig, J., & Duncan, E. L. (2002) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(01)00066-6 · Cited by 119
Rudolph, C., Schillinger, U., Ortiz, A., Tabatt, K., Plank, C., Müller, R. H., & Rosenecker, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041463.56768.ec · Cited by 119
EWS Fli-1 Antisense Nanocapsules Inhibits Ewing Sarcoma-Related Tumor in Mice
Lambert, G., Bertrand, J. R., Fattal, E., Subra, F., Pinto‐Alphandary, H., Malvy, C., Auclair, C., & Couvreur, P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3963 · Cited by 118
Transcriptional Targeting in Cancer Gene Therapy
Robson, T., & Hirst, D. G. (2003) · BioMed Research International · doi:10.1155/s1110724303209074 · Cited by 115
Aynié, I., Vauthier, C., Chacun, H., Fattal, E., & Couvreur, P. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.301 · Cited by 114
Cross-linked polyvinylpyrrolidone nanoparticles: a potential carrier for hydrophilic drugs
Bharali, D. J., Sahoo, S. K., Mozumdar, S., & Maitra, A. (2003) · Journal of Colloid and Interface Science · doi:10.1016/s0021-9797(02)00099-1 · Cited by 112
Folate-Targeted Gene Transfer in Vivo
Hofland, H. E. J., Masson, C., Iginla, S., Osetinsky, I., Reddy, J. A., Leamon, C. P., Scherman, D., Bessodes, M., & Wils, P. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0604 · Cited by 112
In Vivo Gene Transfer by Intravenous Administration of Stable Cationic Lipid/DNA Complex
Hofland, H. E. J., Nagy, D., Liu, J., Spratt, K., Lee, Y., Danos, O., & Sullivan, S. M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012146305040 · Cited by 109
Protamines. Isolation, Characterization, Structure and Function.
Ando, T., Yamasaki, M., & Suzuki, K. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-1-143_5 · Cited by 109
Zhang, Y. P., Sekirov, L., Saravolac, E. G., Wheeler, J. J., Tardi, P. G., Clow, K. A., Leng, E. C., Sun, R. R., Cullis, P. R., & Scherrer, P. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300965 · Cited by 108
Zloković, B. V., & Apuzzo, M. L. J. (1997) · Neurosurgery · doi:10.1097/00006123-199704000-00028 · Cited by 107
Low-pH-Sensitive PEG-Stabilized Plasmid−Lipid Nanoparticles: Preparation and Characterization
Choi, J. S., MacKay, J. A., & Szoka, F. C. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025625w · Cited by 107
Gene therapy using HVJ-liposomes: the best of both worlds?
Kaneda, Y., Saeki, Y., & Morishita, R. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01482-3 · Cited by 106
Pagnan, G., Stuart, D. D., Pastorino, F., Raffaghello, L., Montaldo, P. G., Allen, T. M., Calabretta, B., & Ponzoni, M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.253 · Cited by 106
Vitiello, L., Chonn, A., Wasserman, J. D., Duff, C., & Worton, R. G. (1996) · PubMed · Cited by 104
Photochemical Transfection: A New Technology for Light-Induced, Site-Directed Gene Delivery
Høgset, A., Prasmickaite, L., Tjelle, T. E., & Berg, K. (2000) · Human Gene Therapy · doi:10.1089/10430340050015482 · Cited by 103
Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release
Kunisawa, J., Masuda, T., Katayama, K., Yoshikawa, T., Tsutsumi, Y. M., Akashi, M., Mayumi, T., & Nakagawa, S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.020 · Cited by 102
Schwartz, B., Ivanov, M. A., Pitard, B., Escriou, V., Rangara, R., Byk, G., Wils, P., Crouzet, J., & Scherman, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300795 · Cited by 101
Ko, K. S., Lee, M., Koh, J. J., & Kim, S. W. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0459 · Cited by 97
Mok, K. W. C., Lam, A. M. I., & Cullis, P. R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00059-0 · Cited by 96
Choi, Y. H., Liu, F., Choi, J. S., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950016690 · Cited by 95
DOW, S. W., Elmslie, R. E., Kurzman, I. D., MacEwen, G., Pericle, F., & Liggitt, D. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.937 · Cited by 95
Jeong, J. H. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.07.002 · Cited by 92
Mosqueira, V. C. F., Legrand, P., Gref, R., Heurtault, B., Appel, M., & BARRATT, G. M. (1999) · Journal of drug targeting · doi:10.3109/10611869909085493 · Cited by 92
Koh, J. J., Ko, K. S., Lee, M., Han, S.-Y., Park, J. S., & Kim, S. W. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301334 · Cited by 92
Kircheis, R., Ostermann, E., Wolschek, M. F., Lichtenberger, C., Magin-Lachmann, C., Wightman, L., Kursa, M., & Wagner, E. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700487 · Cited by 90
Lee, C.-H., Ni, Y., Chen, C., Chou, C.-K., & Chang, F. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00027-0 · Cited by 90
A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene
Yu, W. H., Pirollo, K. F., Rait, A. S., Yu, B., Xiang, L., Huang, W.-Q., Zhou, Q., Ertem, G., & Chang, E. H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302304 · Cited by 86
An integrin-targeted non-viral vector for pulmonary gene therapy
Jenkins, G. R., Herrick, S. E., Meng, Q.-H., Kinnon, C., Laurent, G. J., McAnulty, R. J., & Hart, S. L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301095 · Cited by 84
Tagawa, T., Manvell, M. C., Brown, N., Keller, M., Pérouzel, É., Murray, K. D., Harbottle, R. P., Tecle, M., Booy, F. P., Brahimi-Horn, M. C., et al. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301686 · Cited by 84
Gene Transfer with Poly-Melittin Peptides
Chen, C.-P., Kim, J., Steenblock, E. R., Liu, D., & Rice, K. G. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060028l · Cited by 82
Long-circulating vectors for the systemic delivery of genes.
Fenske, D. B., MacLachlan, I., & Cullis, P. R. (2001) · PubMed · Cited by 82
Murray, K. D., Etheridge, C. J., Shah, S. I., Matthews, D. A., Russell, W. C., Gurling, H., & Miller, A. D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301401 · Cited by 81
Volland, M. A. O., Adlhart, C., Kiener, C. A., Chen, P., & Hofmann, P. (2001) · Chemistry - A European Journal · doi:10.1002/1521-3765(20011105)7:21<4730::aid-chem4730>3.0.co;2-a · Cited by 79
Liu, T., Tang, A., Zhang, G., Chen, Y., Zhang, J., Peng, S., & Cai, Z. (2005) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2005.20.141 · Cited by 79
Nakada, Y., Fattal, E., Foulquier, M., & Couvreur, P. (1996) · Pharmaceutical Research · doi:10.1023/a:1016017014573 · Cited by 78
Kommareddy, S., & Amiji, M. M. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701041 · Cited by 77
Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells
Li, X., Stuckert, P., Bosch, I., Marks, J. D., & Marasco, W. A. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700337 · Cited by 77
Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes
Chen, Q.-R., Zhang, L.-Q., Stass, S. A., & Mixson, A. J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301294 · Cited by 74
Hagstrom, J. E., Sebestyén, M. G., Budker, V. G., Ludtke, J. J., Fritz, J. D., & Wolff, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(96)00106-x · Cited by 73
Shi, F., Rakhmilevich, A. L., Heise, C. P., Oshikawa, K., Sondel, P. M., Yang, N.-S., & Mahvi, D. M. (2002) · PubMed · Cited by 73
Collard, W. T., Yang, Y., Kwok, K. Y., Park, Y., & Rice, K. G. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4<499::aid-jps7>3.0.co;2-v · Cited by 72
Astafieva, I. V., Maksimova, I., Lukanidin, E. M., Alakhov, V. Y., & Kabanov, A. V. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00607-2 · Cited by 66
Ndoye, A., Dolivet, G., Høgset, A., Leroux, A., Fifre, A., Erbacher, P., Berg, K., Behr, J., Guillemin, F. H., & Merlin, J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.02.003 · Cited by 65
Colin, M., Harbottle, R. P., Knight, A., Kornprobst, M., Cooper, R., Miller, A. D., Trugnan, G., Capeau, J., Coutelle, C. C., & Brahimi-Horn, M. C. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300760 · Cited by 65
Identification of FGF receptor-binding peptides for cancer gene therapy
Maruta, F., Parker, A. L., Fisher, K. D., Hallissey, M., Ismail, T., Rowlands, D. C., Chandler, L. A., Kerr, R. S., & Seymour, L. W. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700470 · Cited by 61
A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy
Moffatt, S., Wiehle, S., & Cristiano, R. J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302773 · Cited by 57
Romøren, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00278-x · Cited by 55
Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer
Liu, T., Yin, J. Q., Shang, B.-Y., Zhang, M., He, H.-W., Jiang, J.-M., Chen, F., Zhen, Y., & Shao, R. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700753 · Cited by 53
Development of Long-circulating Polyelectrolyte Complexes for Systemic Delivery of Genes
Oupický, D., Ogris, M., & Seymour, L. W. (2002) · Journal of drug targeting · doi:10.1080/10611860290016685 · Cited by 51
Namiki, Y., Takahashi, T., & Ohno, T. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300577 · Cited by 48
Intracellular Visualization of BrdU-labeled Plasmid DNA/Cationic Liposome Complexes
Ouahabi, A. E., Thiry, M., Schiffmann, S. N., Fuks, R., Nguyen-Tran, H., Ruysschaert, J., & Vandenbranden, M. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700908 · Cited by 40
Saxena, A., Mozumdar, S., & Johri, A. K. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.06.029 · Cited by 36
Higuchi, Y., Kawakami, S., Fumoto, S., Yamashita, F., & Hashida, M. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1521 · Cited by 36
Ochietti, B., Guérin, N., Vinogradov, S. V., St‐Pierre, Y., Lemieux, P., Kabanov, A. V., & Alakhov, V. Y. (2002) · Journal of drug targeting · doi:10.1080/10611860290016711 · Cited by 33
Gene Therapy for Cystic Fibrosis Airway Disease- Is Clinical Success Imminent?
Anson, D. S., Smith, G., & Parsons, D. (2006) · Current Gene Therapy · doi:10.2174/156652306776359496 · Cited by 29
Complement Activation by Injectable Colloidal Drug Carriers
Passirani, C., & Benoît, J. (2004) · CRC Press eBooks · doi:10.1201/9780203492321.ch6 · Cited by 27
Self-citationSynthesis of glycosylated polyethylenimine with reduced toxicity and high transfecting efficiency
Leclercq, F., Dubertret, C., Pitard, B., Scherman, D., & Herscovici, J. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00195-5 · Cited by 26
Brignole, C., Marimpietri, D., Pagnan, G., Paolo, D. D., Zancolli, M., Pistoia, V., Ponzoni, M., & Pastorino, F. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.11.065 · Cited by 25
Vaysse, L., & Arveiler, B. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00007-6 · Cited by 23
TerplexDNA gene carrier system targeting artery wall cells
Yu, L. M., Nielsen, M., Han, S., & Kim, S. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00274-7 · Cited by 23
Immunostimulatory activity of cationic-lipid-nucleic-acid complexes against cancer
Dass, C. R. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-001-0318-x · Cited by 18
Cited by
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
Chen, G., Roy, I., Yang, C., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00148 · Cited by 1,499
Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy
Lee, N., Yoo, D., Ling, D., Cho, M. H., Hyeon, T., & Cheon, J. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00112 · Cited by 1,005
Cho, E. C., Xie, J., Wurm, P. A., & Xia, Y. (2009) · Nano Letters · doi:10.1021/nl803487r · Cited by 819
Li, J., Pei, H., Zhu, B., Liang, L., Wei, M., He, Y., Chen, N., Li, D., Huang, Q., & Fan, C. (2011) · ACS Nano · doi:10.1021/nn202774x · Cited by 748
Metadata
- Authors
- Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J.-P.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 29
- Issue
- 24-25
- Pages
- 3477-3496
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2084652077
- Cited by
- 769
- References
- 269
- FWCI
- 21.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.